Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells
- 1 November 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (3) , 775-784
- https://doi.org/10.1016/s0360-3016(01)01714-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Epidermal growth factor-related peptides and their receptors in human malignanciesPublished by Elsevier ,2000
- Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomasBreast Cancer Research and Treatment, 1999
- Her-2/neu as a Predictive Marker of Response to Breast Cancer TherapyBreast Cancer Research and Treatment, 1998
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalJNCI Journal of the National Cancer Institute, 1998
- The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated SignalingJournal of Biological Chemistry, 1997
- A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancerEuropean Journal Of Cancer, 1996
- Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinomaBritish Journal of Cancer, 1996
- Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neckCancer, 1996
- A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Proceedings of the National Academy of Sciences, 1994
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987